Neuropsychology Review

, Volume 19, Issue 2, pp 215–231 | Cite as

Drug Abuse and Hepatitis C Infection as Comorbid Features of HIV Associated Neurocognitive Disorder: Neurocognitive and Neuroimaging Features



Substance abuse and co-infection with hepatitis C (HCV) are two highly relevant determinants of neurocognitive and neuroimaging abnormalities associated with HIV. Substance abuse and HCV are common in the HIV population and there is increasing evidence that the CNS is directly compromised by these comorbid conditions via additive or synergistic processes. In this article we review the current literature regarding mechanisms of neuronal injury as well as the neuropsychological and neuroimaging signatures associated with substance abuse and HCV status among HIV patients. We discuss specific methodological challenges and threats to validity associated with studies of HIV and comorbid substance use disorders or HCV and review potential strategies for minimizing their confounding effects. Efforts to understand the interactions between HIV, substance abuse and HCV co-infection will lead to more complete models of neuropathogenesis of HIV and a greater understanding of the variability in neuropsychological expression of HIV Associated Neurocognitive Disorder.


HIV Drug abuse Hepatitis C Addiction Neurocognition Neuroimaging Dementia 



We thank Raul Gonzalez and two anonymous reviewers for their helpful comments on this article; and Edie Sullivan for her very gracious assistance with our timeline.


  1. Adair, D. M., Radkowski, M., Jablonska, J., Pawelczyk, A., Wilkinson, J., Rakela, J., et al. (2005). Differential display analysis of gene expression in brains from hepatitis C-infected patients. AIDS, 3, S145–S150.Google Scholar
  2. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. The New England Journal of Medicine, 341(8), 556–562.PubMedGoogle Scholar
  3. Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., et al. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69, 1789–1799.PubMedGoogle Scholar
  4. Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144, 705–714.PubMedGoogle Scholar
  5. Aylward, E. H., Brettschneider, P. D., McArthur, J. C., Harris, G. J., Schlaepfer, T. E., Henderer, J. D., et al. (1995). Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. America Journal of Psychiatry, 152, 987–994.Google Scholar
  6. Bagaglio, S., Cinque, P., Racca, S., Pedale, R., Grasso, M. A., Lazzarin, A., et al. (2005). Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients. AIDS, Suppl 3, S151–S165.Google Scholar
  7. Bartok, J., Martin, E. M., Pitrak, D. L., Novak, R. M., Pursell, K. J., Mullane, K. M., et al. (1997). Working memory deficits in HIV-seropositive drug users. Journal of the International Neuropsychological Society, 3, 451–456.PubMedGoogle Scholar
  8. Basso, M. R., & Bornstein, R. A. (2003). Effects of past noninjection drug abuse upon executive function and working memory in HIV infection. Journal of Clinical and Experimental Neuropsychology, 25, 893–903.PubMedGoogle Scholar
  9. Baum, M. K., Jayaweera, D. T., Duan, R., Sales, S., Lai, S., Rafie, C., et al. (2008). Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami. Journal of Addictive Disorders, 27, 37–48.Google Scholar
  10. Bechara, A., Dolan, S., Denburg, N., Hindes, A., Anderson, S. W., & Nathan, P. E. (2001). Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia, 39, 376–389.PubMedGoogle Scholar
  11. Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996). Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. Journal of Personality Assessment, 67, 588–597.PubMedGoogle Scholar
  12. Becker, J. B., & Hu, M. (2008). Sex differences in drug abuse. Frontiers in Neuroendocrinology, 29, 36–47.PubMedGoogle Scholar
  13. Beckley, D. J., Bloem, B. R., Martin, E. M., Panzer, V. P., & Remler, M. P. (1998). Postural reflexes in patients with HIV-1 infection. Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control, 109, 402–408.Google Scholar
  14. Bell, J. E., Brettle, R. P., Chiswick, A., & Simmonds, P. (1998). HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS: Effect of neocortical involvement. Brain, 121, 2043–2052.PubMedGoogle Scholar
  15. Bell, J. E., Arango, J.-C., & Anthony, I. C. (2006). Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs. Journal of Neuroimmune Pharmacology, 1, 1557–1890.Google Scholar
  16. Berger, J. R., & Arendt, G. (2000). HIV dementia: The role of the basal ganglia and dopaminergic systems. Journal of Psychopharmacology, 14, 214–221.PubMedGoogle Scholar
  17. Biederman, J., Wilens, T. E., Mick, E., Faraone, S. V., & Spencer, T. (1998). Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biological Psychiatry, 44, 269–273.PubMedGoogle Scholar
  18. Bitsch, A., Bruhn, H., Vougioukas, V., Stringaris, A., Lassmann, H., Frahm, J., et al. (1999). Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. American Journal of Neuroradiology, 20, 1619–1627.PubMedGoogle Scholar
  19. Bornstein, R. A., Chakeres, D., Brogan, M., Nasrallah, H. A., Fass, R. J., Para, M., et al. (1992). Magnetic resonance imaging of white matter lesions in HIV infection. The Journal of Neuropsychiatry and Clinical Neurosciences, 4, 174–178.PubMedGoogle Scholar
  20. Bouwman, F. H., Skolasky, R. L., Hes, D., Selnes, O. A., Glass, J. D., Nance-Sproson, N., et al. (1998). Variable progression of HIV-associated dementia. Neurology, 50, 1814–1820.PubMedGoogle Scholar
  21. Braitstein, P., Montessori, V., Chan, K., Montaner, J. S., Schechter, M. T., O’Shaughnessy, M. V., et al. (2005). Variable progression of HIV-associated dementia. AIDS Care, 17, 505–515.PubMedGoogle Scholar
  22. Brand, M., Roth-Bauer, M., Driessen, M., & Markowitsch, H. J. (2008). Executive functions and risky decision-making in patients with opiate dependence. Drug and Alcohol Dependence, 97, 64–72.PubMedGoogle Scholar
  23. Bruce, R. D., Altice, F. L., Gourevitch, M. N., & Friedland, G. H. (2006). Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: Implications and management for clinical practice. Journal of Acquired Immune Deficiency Syndrome, 163, 412–420.Google Scholar
  24. Bruce, R. D., Altice, F. L., & Friedland, G. H. (2008). Pharmacokinetic drug interactions between drugs of abuse and antiretroviral medications: implications and management for clinical practice Expert Review of Clinical Pharmacology, 1, 115–127.Google Scholar
  25. Budka, H., Wiley, C. A., Kleihues, P., Artiga, J., Asbury, A. K., Cho, E. S., et al. (1991). HIV-associated disease of the nervous system: Review of nomenclature and proposal for neuropathology-based terminology. Brain Pathology, 1, 143–152.PubMedGoogle Scholar
  26. Carey, C. L., Woods, S. P., Rippeth, J. D., Gonzalez, R., Heaton, R. K., Grant, I., et al. (2006). Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS and Behavior, 10, 185–190.PubMedGoogle Scholar
  27. Castelo, J. M. B., Courtney, M. G., Melrose, R. J., & Stern, C. E. (2007). Putamen hypertrophy in nondemented patients with Human Immunodeficiency Virus infection and cognitive compromise. Archives of Neurology, 64, 1275–1280.PubMedGoogle Scholar
  28. Chana, G., Everall, I. P., Crew, L., Langford, D., Adame, A., Grant, I., et al. (2006). Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology, 67, 1486–1489.PubMedGoogle Scholar
  29. Chang, L., Ernst, T., Leonido-Yees, M., Walot, I., & Singer, E. (1999). Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology, 52, 100–108.PubMedGoogle Scholar
  30. Chang, L., Cloak, C., Yakupov, R., & Ernst, T. (2006). Combined and independent effects of chronic marijuana use and HIV on brain metabolites. Journal of Neuroimmune Pharmacology, 1, 1–12.Google Scholar
  31. Chang, L., Daniel, A., Ernst, T., & Volkow, N. (2007). Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction, 102, 16–32.PubMedGoogle Scholar
  32. Chang, L., Ernst, T., Speck, O., & Grob, C. S. (2005). Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. American Journal of Psychiatry, 162, 361–369.PubMedGoogle Scholar
  33. Chang, L., Wang, G. J., Volkow, N. D., Ernst, T., Telang, F., Logan, J., et al. (2008). Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage, 42, 869–878.PubMedGoogle Scholar
  34. Cherner, M., Masliah, E., Ellis, R. J., Marcotte, T. D., Moore, D. J., Grant, I., et al. (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology, 59, 1563–1567.PubMedGoogle Scholar
  35. Cherner, M., Letendre, S., Heaton, R. K., Durelle, J., Marquie-Beck, J., Gragg, B., et al. (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64, 1343–1347.PubMedGoogle Scholar
  36. Chilcoat, H. D., & Breslau, N. (1998). Posttraumatic stress disorder and drug disorders: Testing causal pathways. Archives of General Psychiatry, 55, 913–917.PubMedGoogle Scholar
  37. Clifford, D. B., Evans, S. R., Yang, Y., & Gulick, R. M. (2005). The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. AIDS, 19, S64–S71.PubMedGoogle Scholar
  38. Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability and comorbidity of DSM-IV drug abuse and dependence in the United States. Archives of General Psychiatry, 64, 566–576.PubMedGoogle Scholar
  39. Concha, M., Graham, N. M. H., Munoz, A., Vlahov, D., Royal, W., Updike, M., et al. (1992). Effect of chronic substance abuse on the neuropsychological performance of Intravenous Drug Users with a high prevalence of HIV-1 seropositivity. American Journal of Epidemiology, 1336, 1338–1348.Google Scholar
  40. Cristiani, S. A., Pukay-Martin, N. D., & Bornstein, R. A. (2004). Marijuana use and cognitive function in HIV-infected people. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 330–335.PubMedGoogle Scholar
  41. Cysique, L. A., Maruff, P., & Brew, B. J. (2004). Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus–infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two. Journal of Neurovirology, 10, 350–357.PubMedGoogle Scholar
  42. Dawes, S., Suarez, P., Casey, C. Y., Cherner, M., Marcotte, T. D., Letendre, S., et al. (2008). Variable patterns of neuropsychological performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology, 30, 613–626.PubMedGoogle Scholar
  43. Dhillon, N. K., Williams, R., Peng, F., Tsai, Y., Dhillon, S., Nicolay, B., et al. (2007). Cocaine mediated enhancement of virus replication in macrophages: Implications for human immunodeficiency virus-associated dementia. Journal of Neurovirology, 13, 483–495.PubMedGoogle Scholar
  44. Durazzo, T., Rothlind, J., Cardenas, V., Studholme, C., Weiner, M., & Meyerhoff, D. (2007). Chronic cigarette smoking and heavy drinking in human immunodeficiency virus: consequences for neurocognition and brain morphology. Alcohol, 41, 489–501.PubMedGoogle Scholar
  45. Durvasula, R. S., Myers, H. F., Satz, P., Miller, E. N., Morgenstern, H., Richardson, M. A., et al. (2000). HIV-1, cocaine, and neuropsychological performance in African American men. Journal of the International Neuropsychological Society, 6, 322–335.PubMedGoogle Scholar
  46. Durvasula, R. S., Myers, H. F., Mason, K., & Hinkin, C. (2006). Relationship between alcohol use/abuse, HIV infection and neuropsychological performance in African American men. Journal of Clinical and Experimental Neuropsychology, 28, 383–404.PubMedGoogle Scholar
  47. Egan, V., Brettle, R. P., & Goodwin, G. M. (1992). The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease. British Journal of Psychiatry, 161, 522–531.PubMedGoogle Scholar
  48. Farinpour, R., Martin, E., Seidenberg, M., Pitrak, D. L., Pursell, K. J., Mullane, K. M., et al. (2000). Verbal working memory in HIV-seropositive drug users. Journal of the International Neuropsychological Society, 5, 548–555.Google Scholar
  49. Filippi, C. G., Ulug, A. M., Ryan, E., Ferrando, S. J., & van Gorp, W. (2001). Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. American Journal of Neuroradiology, 277-283.Google Scholar
  50. Fillmore, M. T., & Rush, C. R. (2002). Impaired inhibitory control of behavior in chronic cocaine users. Drug and Alcohol Dependence, 66, 265–273.PubMedGoogle Scholar
  51. Fillmore, M. T., Rush, C. R., & Hays, L. (2002). Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug and Alcohol Dependence, 67, 157–167.PubMedGoogle Scholar
  52. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. (1996). Structured clinical interview for DSM-IV Axis I disorders. New York: Biometrics Research Department.Google Scholar
  53. Flora, G., Lee, Y. W., Nath, A., Hennig, B., Maragos, W., & Toborek, M. (2003). Methamphetamine potentiates HIV-1 tat protein-mediated activation of redoxsensitive pathways in discrete regions of the brain. Experimental Neurology, 179, 60–70.PubMedGoogle Scholar
  54. Flora, G., Pu, H., Lee, Y. W., Ravikumar, R., Nath, A., Hennig, B., et al. (2005). Proinflammatory synergism of ethanol and HIV-1 tat protein in brain tissue. Experimental Neurology, 191, 2–12.PubMedGoogle Scholar
  55. Flores, S. C., & McCord, J. M. (1998). Oxidative stress and human immunodeficiency virus. Advances in Molecular and Cell Biology, 25, 71–94.Google Scholar
  56. Fontana, R. J., Bieliauskas, L. S., Back-Madruga, C., Lindsay, K. L., Kronfol, Z., et al. (2005). Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. Journal of Hepatology, 43, 614–622.PubMedGoogle Scholar
  57. Forman, S. D., Dougherty, G. G., Casey, B. J., Siegle, G. J., Braver, T. S., Barch, D. M., et al. (2004). Opiate addicts lack error-dependent activation of rostral anterior cingulate. Biological Psychiatry, 55, 531–537.PubMedGoogle Scholar
  58. Forton, D. M., Allsop, J. M., Main, J., Foster, G., Thomas, H., & Taylor-Robinson, S. (2001). Evidence for a cerebral effect of the hepatitis C virus. Lancet, 358, 38–39.PubMedGoogle Scholar
  59. Forton, D. M., Thomas, H. C., Murphy, C. A., Allsop, J. M., Foster, G. R., Main, J., et al. (2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology, 35, 433–439.PubMedGoogle Scholar
  60. Forton, D. M., Karayiannis, P., Mahmud, N., Taylor-Robinson, S. D., & Thomas, H. C. (2004). Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. Journal of Virology, 78, 5170–5183.PubMedGoogle Scholar
  61. Forton, D. M., Allsop, J. M., Cox, I. J., Hamilton, G., Wesnes, K., Thomas, H. C., et al. (2005). A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS, Suppl, 3, S53–S63.Google Scholar
  62. Forton, D. M., Hamilton, G., Allsop, J. M., Grover, V. P., Wesnes, K., O'Sullivan, C., et al. (2008). Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study. Journal of Hepatology, 49, 316–322.PubMedGoogle Scholar
  63. Garden, G. A. (2002). Microglia in human immunodeficiency virus-associated neurodegeneration. Glia, 40, 240–251.PubMedGoogle Scholar
  64. Goldstein, R. Z., & Volkow, N. D. (2002). Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. American Journal of Psychiatry, 159, 1642–1652.PubMedGoogle Scholar
  65. Gonzalez, R., Jacobus, J., & Martin, E. M. (2005a). Investigating neurocognitive features of hepatitis C virus infection in drug users: Potential challenges and lessons learned from the HIV literature. Clinical Infectious Diseases, 41, S45–S49.PubMedGoogle Scholar
  66. Gonzalez, R., Vassileva, J., Bechara, A., Grbesic, S., Sworowski, L., Novak, R. M., et al. (2005b). The influence of executive functions, sensation seeking, and HIV serostatus on the risky sexual practices of substance dependent individuals. Journal of the International Neuropsychological Society, 11, 121–131.PubMedGoogle Scholar
  67. Gonzalez, R., Rippeth, J. D., Carey, C. L., Heaton, R. K., Moore, D. J., Schweinsburg, B. C., et al. (2004). Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug and Alcohol Dependence, 76, 181–190.PubMedGoogle Scholar
  68. Gonzalez, R., Jacobus, J., Vassileva, J., Quartana, P., Amatya, A., & Martin, E. (2008). Deficits in complex motor functions, despite no evidence of procedural learning deficits, among HIV+ individuals with history of substance dependence. Neuropsychology, 22, 240–251.Google Scholar
  69. Grant, S., Contoreggi, C., & London, E. D. (2000). Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia, 38, 1180–1187.PubMedGoogle Scholar
  70. Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L., & Wolfson, T. (2003). Non-acute residual neurocognitive effects of cannabis use: A meta-analytic study. Journal of the International Neuropsychological Society, 9, 679–689.PubMedGoogle Scholar
  71. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., et al. (2004a). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders Archives of General Psychiatry, 61, 807–816.Google Scholar
  72. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, J., & Pickering, R. P. (2004b). Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States. Archives of General Psychiatry, 61, 361–368.PubMedGoogle Scholar
  73. Green, J. E., Saveanu, R. V., & Bornstein, R. A. (2004). The effect of previous alcohol abuse on cognitive function in HIV infection. American Journal of Psychiatry, 161, 249–254.PubMedGoogle Scholar
  74. Hauser, K. F., El-Hage, N., Buch, S., Nath, A., Tyor, W. R., Bruce-Keller, W. R., et al. (2006). Impact of opiate-HIV-1 interactions on neurotoxic signaling. Journal of Neuroimmune Pharmacology, 1, 98–105.PubMedGoogle Scholar
  75. Heaton, R. K., Velin, R. A., McCutchan, J. A., Gulevich, S. J., Atkinson, H., Wallace, M. R., et al. (1994). Neuropsychological impairment in human immunodeficiency virus-infection: Implications for employment. Psychosomatic Medicine, 56, 8–17.PubMedGoogle Scholar
  76. Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J., Moore, D. J., Bentley, H., et al. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10, 317–331.PubMedGoogle Scholar
  77. Hestad, K., Aukrust, P., Ellertson, B., Kløve, H., & Wilberg, K. (1993). Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users. Journal of Clinical and Experimental Neuropsychology, 15, 732–742.PubMedGoogle Scholar
  78. Hilsabeck, R. C., Hassanein, T. I., Carlson, M. D., Ziegler, E. A., & Perry, W. (2003). Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. Journal of the International Neuropsychological Society, 9, 847–854.PubMedGoogle Scholar
  79. Hilsabeck, R. C., Castellon, S. A., & Hinkin, C. H. (2005). Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clinical Infectious Diseases, 41, S38–S44.PubMedGoogle Scholar
  80. Hilsabeck, R. C., Perry, W., & Hassanein, T. I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology, 35, 440–446.PubMedGoogle Scholar
  81. Hinkin, C. H., Hardy, D. J., Mason, K. L., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18, S19–S25.PubMedGoogle Scholar
  82. Hinkin, C. H., Castellon, S. A., Levine, A. J., Barclay, T. R., & Singer, E. J. (2008). Neurocognition in individuals co-infected with HIV and hepatitis C. AIDS, 27, 11–17.Google Scholar
  83. Hu, S., Sheng, W. S., Lokensgard, J. R., & Peterson, P. K. (2005). Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. Journal of Infectious Disease, 191, 886–889.Google Scholar
  84. Huckans, M., Seelye, A., Parcel, T., Mull, L., Woodhouse, J., Bjornson, D., et al. (2009). The cognitive effects of hepatitis C in the presence and absence of a history of substance abuse disorder. Journal of the International Neuropsychological Society, 15, 69–82.PubMedGoogle Scholar
  85. Janssen, R. S., Cornblath, D. R., Epstein, L. G., Foa, R. P., McArthur, J. C., & Price, R. W. (1991). Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1). Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology, 41, 778–785.Google Scholar
  86. Jernigan, T. L., Gamst, A. C., Archibald, S. L., Fennema-Notestine, C., Mindt, M. R., Marcotte, T. L., et al. (2005). Effects of methamphetamine dependence and HIV infection on cerebral morphology. American Journal of Psychiatry, 162, 1461–1472.PubMedGoogle Scholar
  87. Kalechstein, A. D., Newton, T. F., & Green, M. (2003). Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 215–220.PubMedGoogle Scholar
  88. Kalechstein, A., & van Gorp, W. (2007) Neuropsychology and substance use. New York: Taylor & Francis.Google Scholar
  89. Kalivas, P. W., & Volkow, N. D. (2005). The neural basis of addiction: pathology of motivation and choice. American Journal of Psychiatry, 162, 1403–1413.PubMedGoogle Scholar
  90. Kanmogne, G. D., Kennedy, R. C., & Grammas, P. (2002). HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: Possible pathway for HIV entry into the brain and HIV associated dementia. Journal of Neuropathology and Experimental Neurology, 61, 992–1000.PubMedGoogle Scholar
  91. Kapadia, F., Vlahov, D., Donahoe, R. M., & Friedland, G. (2005). The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clinical Infectious Diseases, 41, 1027–1034.PubMedGoogle Scholar
  92. Kaufman, J. N., Ross, T. J., Stein, E. A., & Garavan, H. (2003). Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. Journal of Neuroscience, 23, 7839–7843.PubMedGoogle Scholar
  93. Keane, T. M., Wolfe, J., & Taylor, K. L. (1987). Post-traumatic stress disorder: Evidence for diagnostic validity and methods of psychological measurement. Journal of Clinical Psychology, 43, 32–43.PubMedGoogle Scholar
  94. Kellogg, S. H., McHugh, P. F., Bell, K., Schluger, J. H., Schluger, R. P., LaForge, K. S., et al. (2003). The Kreek-McHugh-Schluger-Kellogg scale: A new, rapid method for quantifying substance abuse and its possible applications. Drug and Alcohol Dependence, 69, 137–150.PubMedGoogle Scholar
  95. Khurdayan, V. K., Buch, S., El-Hage, N., Lutz, S. E., Goebel, S. M., Singh, I. N., et al. (2004). Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. European Journal of Neuroscience, 19, 3171–3182.PubMedGoogle Scholar
  96. Kilts, C. D., Gross, R., Ely, T. D., & Drexler, K. P. G. (2004). The neural correlates of cue-induced craving in cocaine-dependent women. American Journal of Psychiatry, 161, 233–241.PubMedGoogle Scholar
  97. Kirby, K. N., & Petry, N. M. (2004). Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction, 99, 461–471.PubMedGoogle Scholar
  98. Knowlton, B. J., Mangels, J. A., & Squire, L. R. (1996). A neostriatal habit learning system in humans. Science, 273, 1399–1402.PubMedGoogle Scholar
  99. Langford, D., Adame, A., Grigorian, A., Grant, I., McCutchan, J. A., Ellis, R. J., et al. (2003). Patterns of selective neuronal damage in methamphetamine-user AIDS patients. Journal of the Immune Deficiency Syndrome, 34, 467–474.Google Scholar
  100. Langford, T. D., Letendre, S. L., Larrea, G. J., & Masliah, E. (2006). Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathology, 13, 195–210.Google Scholar
  101. Laskus, T., Radkowski, M., Bednarska, A., Wilkinson, J., Adair, D., Nowicki, M., et al. (2002). Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. Journal of Virology, 76, 10064–10068.PubMedGoogle Scholar
  102. Laskus, T., Radkowski, M., Jablonska, J., Kibler, K., Wilkinson, J., Adair, D., et al. (2004). Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood, 103, 3854–3859.PubMedGoogle Scholar
  103. Letendre, S. L., Cherner, M., Ellis, R. J., Marquie-Beck, J., Gragg, B., Marcotte, T., et al. (2005). The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: Biological correlates of disease. AIDS, 19, S72–S78.PubMedGoogle Scholar
  104. Letendre, S., Paulino, A. D., Rockenstein, E., Adame, A., Crews, L., Cherner, M., et al. (2007). Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. Journal of Infectious Disease, 196, 361–370.Google Scholar
  105. Levenson, M. R., Kiehl, K. A., & Fitzpatrick, C. M. (1995). Assessing psychopathic attributes in a non institutionalized population. Journal of Personality and Social Psychology, 68, 151–158.PubMedGoogle Scholar
  106. Levine, A. J., Hardy, D. J., Miller, E., Castellon, S. A., Longshore, D., & Hinkin, C. H. (2006). The effect of recent stimulant use on sustained attention in HIV-infected adults. Journal of Clinical and Experimental Neuropsychology, 28, 29–42.PubMedGoogle Scholar
  107. Liang, H., Wang, X., Chen, H., Song, L., Ye, L., Wang, S.-H., et al. (2008). Methamphetamine enhances HIV infection of macrophages. American Journal of Pathology, 172, 1617–1624.PubMedGoogle Scholar
  108. Lucas, G. M., Griswold, M., Gebo, K. A., Keruly, J., Chaisson, R. E., & Moore, R. D. (2006). Illicit drug use and HIV-1 disease progression: A longitudinal study in the era of Highly Active Antiretroviral Therapy. American Journal of Epidemiology, 163, 412–420.PubMedGoogle Scholar
  109. Maggi, F., Giorgi, M., Fornai, C., Morrica, A., Vatteroni, M. L., Pistello, M., et al. (1999). Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. Journal of Neurovirology, 5, 319–323.PubMedGoogle Scholar
  110. Marcellin, F., Preau, M., Ravaux, I., Dellamonica, P., Spire, B., & Carrieri, M. P. (2007). Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: Implications for clinical management and future research. HIV Clinical Trials, 8, 320–327.PubMedGoogle Scholar
  111. Marcotte, T. D., Heaton, R. K., Wolfson, T., Taylor, M. J., Alhassoon, O., Arfaa, K., et al. (1999). The impact of HIV-related neuropsychological dysfunction on driving behavior. Journal of the International Neuropsychological Society 5, 579–592.Google Scholar
  112. Marder, K., Stern, Y., Malouf, R., Tang, M.-X., Bell, K., Dooneief, G., et al. (1992). Neurologic and neuropsychological manifestations of Human Immunodeficiency Virus Infection in intravenous drug users without Acquired Immunodeficiency Syndrome; Relationship to head injury. Archives of Neurology, 49, 1169–1175.PubMedGoogle Scholar
  113. Martin, A., Heyes, M. P., Salazar, A. M., Law, W. A., & Williams, J. (1993). Impaired motor-skill learning, slowed reaction time, and elevated cerebrospinal fluid quinolinic acid in a subgroup of HIV-infected individuals. Neuropsychology, 7, 149–157.Google Scholar
  114. Martin, E., Pitrak, D. L., Weddington, W., Rains, N. A., Nunnally, G., Nixon, H., et al. (2004a). Cognitive impulsivity and HIV serostatus in substance dependent males. Journal of the International Neuropsychological Society, 7, 931–938.Google Scholar
  115. Martin, E. M., Sullivan, T. S., Reed, R. A., Fletcher, T. A., Pitrak, D. L., Weddington, W., et al. (2001). Auditory working memory in HIV-1 infection. Journal of the International Neuropsychological Society, 7, 20–26.1.PubMedGoogle Scholar
  116. Martin, E. M., Pitrak, D. L., Rains, M. A., Grbesic, S., Pursell, K., Nunnally, G., et al. (2003). Delayed non match to sample performance in HIV-seropositive and HIV-seronegative polydrug abusers. Neuropsychology, 17, 283–288.PubMedGoogle Scholar
  117. Martin, E. M., Novak, R. M., Fendrich, M., Vassileva, J., Gonzalez, R., Grbesic, S., et al. (2004b). Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. Journal of the International Neuropsychological Society, 10, 298–300.PubMedGoogle Scholar
  118. Martin, E. M., Nixon, H., Pitrak, D. L., Weddington, W., Rains, N. A., Nunnally, G., et al. (2007). Characteristics of prospective memory deficits in HIV-seropositive substance dependent individuals. Journal of Clinical and Experimental Neuropsychology, 29, 496–504.PubMedGoogle Scholar
  119. McLellan, A. T., Luborsky, L., Cacciola, J., Griffith, J., Evans, F., Barr, H. L., et al. (1985). New data from the Addiction Severity Index: Reliability and validity in three centers. Journal of Nervous and Mental Disease, 173, 412–423.PubMedCrossRefGoogle Scholar
  120. Meyerhoff, D. J., MacKay, S., Sappey-Marinier, D., Deicken, R., Calabrese, G., Dillon, W. P., et al. (1995). Effects of chronic alcohol abuse and HIV infection on brain phosphorus metabolites. Alcoholism: Clinical Experimental Research, 19, 685–692.Google Scholar
  121. Mintzer, M. Z., & Stitzer, M. L. (2002). Cognitive impairment in methadone maintenance patients. Drug and Alcohol Dependence, 67, 41–51.PubMedGoogle Scholar
  122. Morgello, S. (2005). The nervous system and hepatitis C virus. Seminars in Liver Disease, 25, 118–121.PubMedGoogle Scholar
  123. Morgello, S., Estanislao, L., Ryan, E., Geritis, P., Simpson, D., Verma, S., et al. (2005). Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals. AIDS, Suppl, 3, S116–S122.Google Scholar
  124. Murray, J., Fishman, S. L., Ryan, E., Eng, F. J., Walewski, J. L., Branch, A. D., et al. (2008). Clinicopathologic correlates of hepatitis C virus in brain: A pilot study. Journal of Neurovirology, 14, 17–27.PubMedGoogle Scholar
  125. Nath, A., Maragos, W. F., Avison, M. J., Schmitt, F. A., & Berger, J. R. (2001). Acceleration of HIV dementia with methamphetamine and cocaine. Journal of Neurovirology, 7, 66–71.PubMedGoogle Scholar
  126. Nath, A., Hauser, K. F., Wojna, V., Booze, R. M., Maragos, W., Prendergast, M., et al. (2002). Molecular basis for interactions of HIV and drugs of abuse. Journal of Acquired Immune Deficiency Syndromes, 31, S62–S69.PubMedGoogle Scholar
  127. Nath, A., Schiess, N., Venkatesan, A., Rumbaugh, J., Sacktor, N., & McArthur, J. (2008). Evolution of HIV dementia with HIV infection. International Review of Psychiatry, 20, 25–31.PubMedGoogle Scholar
  128. Navia, B. A., Jordan, B. D., & Price, R. W. (1986). The AIDS dementia complex: I. Clinical features. Annals of Neurology, 19, 517–524.Google Scholar
  129. Nordahl, T. E., Salo, R., & Leamon, M. (2003). Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 317–325.PubMedGoogle Scholar
  130. Paul, R., Cohen, R., & Navia, B. (2002). Neuroimaging relationships to cognition in patients with HIV. Neurosciences and Biobehavioral Reviews, 26, 353–359.Google Scholar
  131. Paul, R., Letendre, S., & Dearborn, J. (2007). Impact of hepatitis C coinfection on cognitive outcomes in HIV infected individuals. Current Hepatitis Reports, 6, 145–152.Google Scholar
  132. Perry, W., Carlson, M. D., Barakat, F., Hilsabeck, R. C., Schiehser, D. M., Mathews, C., et al. (2005). Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. AIDS, 19(Suppl 3), S79–S84.PubMedGoogle Scholar
  133. Perry, W., Hilsabeck, R. C., & Hassanein, T. I. (2008). Cognitive dysfunction in chronic hepatitis C: A review. Digestive Diseases Sciences, 53, 307–321.Google Scholar
  134. Petry, N. M. (2001). Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology, 154, 243–250.PubMedGoogle Scholar
  135. Pfefferbaum, A., Rosenbloom, M., & Sullivan, E. V. (2002). Alcoholism and AIDS: Magnetic resonance imaging approaches for detecting interactive neuropathology. Alcoholism: Clinical and Experimental Research, 26, 1031–1046.Google Scholar
  136. Pfefferbaum, A., Rosenbloom, M. J., Rohlfing, T., Adalsteinsson, E., Kemper, C. A., Deresinski, S., et al. (2006). Contribution of alcoholism to brain dysmorphology in HIV infection: effects on the ventricles and corpus callosum. Neuroimage, 33, 239–251.PubMedGoogle Scholar
  137. Pfefferbaum, A., Rosenbloom, M. J., Adalsteinsson, E., & Sullivan, E. V. (2007). Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity: Synergistic white matter damage. Brain, 130, 48–64.PubMedGoogle Scholar
  138. Pomara, N., Crandall, D. T., Choi, S. J., Johnson, G., & Lim, K. O. (2001). White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Research, 28, 15–24.Google Scholar
  139. Richter, K. P., Ahluwalia, H. K., Mosier, M. C., Nazir, N., & Ahluwalia, J. S. (2002). A population-based study of cigarette smoking among illicit drug users in the United States. Addiction, 97, 861–869.PubMedGoogle Scholar
  140. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., et al. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10, 1–14.PubMedGoogle Scholar
  141. Rogers, R. D., Everitt, B. J., Baldacchino, A., Blackshaw, R., Swainson, R., Wynne, K., et al. (1999). Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology, 20, 322–339.PubMedGoogle Scholar
  142. Rothlind, J. C., Greenfield, T. M., Bruce, A. V., Meyerhoff, D. J., Lindgren, J. A., & Weiner, M. W. (2005). Heavy alcohol consumption in individuals with HIV infection: Effects on neuropsychological performance. Journal of the International Neuropsychological Society, 11, 70–83.PubMedGoogle Scholar
  143. Ryan, E. L., Morgello, S., Isaacs, K., Naseer, M. G., Gerits, P., & Manhattan HIV Brain Bank. (2004). The neuropsychiatric impact of hepatitis C on advanced HIV. Neurology, 62, 957–962.PubMedGoogle Scholar
  144. Sassoon, S. A., Fama, R., Rosenbloom, M. J., O’Reilly, A., Pfefferbaum, A., & Sullivan, E. V. (2007). Component cognitive and motor processes of the Digit Symbol Test. Alcoholism: Clinical and Experimental Research, 31, 1315–1324.Google Scholar
  145. Schulte, T., Mueller-Oehring, E. M., Rosenbloom, M. J., Pfefferbaum, A., & Sullivan, E. V. (2005). Differential effect of HIV infection and alcoholism on conflict processing, attentional allocation, and perceptual load: Evidence from a Stroop match-to-sample task. Biological Psychiatry, 57, 67–75.PubMedGoogle Scholar
  146. Selnes, O. A., McArthur, J. C., Royal, W., Updike, L., Nance-Sproson, T., Concha, M., et al. (1992). HIV-1 infection and intravenous drug use: Longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology, 42, 1924.PubMedGoogle Scholar
  147. Shiu, C., Barbier, E., Di Cello, F., Choi, H. J., & Stins, M. (2006). HIV-1 gp120 as well as alcohol affect blood–brain barrier permeability and stress fiber formation: Involvement of reactive oxygen species. Alcoholism: Clinical and Experimental Research, 31, 130–137.Google Scholar
  148. Starace, F., Baldassare, C., Biancolili, V., Fea, M., Serpelloni, G., Bartoli, L., et al. (1998). Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study. Acta Psychiatrica Scandinavica, 97, 132–138.PubMedGoogle Scholar
  149. Stebbins, G. T., Smith, C. A., Bartt, R. E., Kessler, H. A., Adeyemi, O. M., Martin, E., et al. (2007). HIV-associated alterations in normal-appearing white matter: A voxel-wise diffusion tensor imaging study. Journal of the Acquired Immune Deficiency Syndrome, 46, 564–573.Google Scholar
  150. Stein, M. A., Sandoval, R., Szumowski, E., Roizen, N., Reinecke, M. A., Blondis, T. A., et al. (1995). Psychometric characteristics of the Wender Utah Rating Scale (WURS): Reliability and factor structures for men and women. Psychopharmacology Bulletin, 31, 425–433.PubMedGoogle Scholar
  151. Strider, D. B. (2005). Coinfection with HIV and hepatitis C virus in injection drug users and minority populations. Clinical Infectious Disease, 4, S7–S13.Google Scholar
  152. Sulkowski, M. S., Moore, R. D., Mehta, S. H., Chaisson, R. E., & Thomas, D. L. (2002). Hepatitis C progression of HIV disease. Journal of the American Medical Association, 288, 199–206.PubMedGoogle Scholar
  153. Taylor, M. J., Letendre, S. L., Schweinsburg, B. C., Alhassoon, O. M., Brown, G. G., Gongvatana, A., et al. (2004). Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users. Journal of the International Neuropsychological Society, 10, 110–113.PubMedGoogle Scholar
  154. Theodore, S., Cass, W. A., & Maragos, W. F. (2006). Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Neuroscience, 137, 925–935.PubMedGoogle Scholar
  155. Tillmann, H. L., Kaiser, T., Claes, C., Schmidt, R. E., Manns, M. P., & Stoll, M. (2006). Differential influence of different hepatitis viruses on quality of life in HIV positive patients. European Journal of Medical Research, 11, 381–385.PubMedGoogle Scholar
  156. Tsui, J. I., Bangsberg, D. R., Ragland, K., Hall, C. S., & Riley, E. D. (2007). The impact of chronic hepatitis C on health-related quality of life in homeless and marginally housed individuals with HIV. AIDS and Behavior, 11, 603–610.PubMedGoogle Scholar
  157. Tucker, K., Robertson, K., Lin, W., Smith, J. A. H., Chen, Y., Aylward, S., et al. (2004). Neuroimaging in human immunodeficiency virus infection. Journal of Neuroimmunology, 157, 153–162.PubMedGoogle Scholar
  158. van Gorp, W. G., & Hinkin, C. H. (2005). Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine. Neurology, 64, 1328–1329.PubMedGoogle Scholar
  159. van Gorp, W. G., Wilkins, J. N., Hinkin, C. H., Moore, L. H., Hull, J., Horner, M. D., et al. (1999). Declarative and procedural memory functioning in abstinent cocaine abusers. Archives of General Psychiatry, 56, 85–89.PubMedGoogle Scholar
  160. Vassileva, J., Gonzalez, R., Bechara, A., & Martin, E. (2007a). Are all drug addicts impulsive? Effects of antisociality and extent of multidrug use on cognitive and motor impulsivity. Addictive Behaviors, 32, 3071–3076.PubMedGoogle Scholar
  161. Vassileva, J., Petkova, P., Georgiev, S., Martin, E. M., Tersiyski, R., Raycheva, M., et al. (2007b). Impaired decision-making in psychopathic heroin addicts. Drug and Alcohol Dependence, 86, 287–289.PubMedGoogle Scholar
  162. Vassilopoulos, D., & Calabrese, L. H. (2005). Extrahepatic immunological complications of hepatitis C virus infection. AIDS, 19(Suppl. 3), S123–S127.PubMedGoogle Scholar
  163. Verucchi, G., Calza, L., Manfredi, R., & Chiodo, F. (2004). Human immunodeficiency virus and hepatitis C virus coinfection: Epidemiology, natural history, therapeutic options and clinical management. Infection, 32, 33–46.PubMedGoogle Scholar
  164. Vigil, O., Posada, C., Woods, S. P., Atkinson, J. H., Heaton, R. K., Perry, W., et al. (2008). Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection. Journal of Clinical and Experimental Neuropsychology, 4, 1–11.Google Scholar
  165. von Giesen, H. J., Heintges, T., Abbasi-Boroudjeni, N., Kücükköylü, S., Köller, H., Haslinger, B. A., et al. (2004). Psychomotor slowing in hepatitis C and HIV infection. Journal of Acquired Immune Deficiency Syndrome, 35, 131–137.Google Scholar
  166. Wang, J. H., Liu, X. F., Chen, Y. M., Sun, H. Y., Fu, Y., Ma, M. X., et al. (2007). Heroin impairs map-picture-following and memory tasks dependent on gender and orientation of the tasks. Behavioral Neuroscience, 121, 653–644.PubMedGoogle Scholar
  167. Wechsler, D. (2001). Wechsler Test of Adult Reading. San Antonio, TX: The Psychological Corporation.Google Scholar
  168. Wetherington, C. L. (2007). Sex-gender differences in drug abuse: A shift in the burden of proof? Experimental and Clinical Psychopharmacology, 15, 411–417.PubMedGoogle Scholar
  169. Wilkinson, J., Radkowski, M., & Laskus, T. (2008). Hepatitis C virus neuroinvastion: Identification of infected cells. Journal of Virology, 83, 1312–1319.PubMedGoogle Scholar
  170. Zuckerman, M. (1996). The psychobiological model for impulsive unsocialized sensation seeking: A comparative approach. Neuropsychobiology, 34, 125–129.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.University of Illinois and Jesse Brown VA Medical CenterChicagoUSA
  2. 2.University of MissouriSt LouisUSA
  3. 3.Washington UniversitySt LouisUSA

Personalised recommendations